Die Jules Millogo | Director of Public Health Partnerships
merck

Die Jules Millogo, Director of Public Health Partnerships, merck

Dr. Jules Millogo is a Public Health physician with more than 30 years of experience working in developing countries at national and international levels. He joined Merck Vaccines as Medical Director, Public Health Partnerships in August 2010.  In this position he serves as Merck’s liaison with the World Health Organization (WHO) and supports Merck’s engagements with other global immunization stakeholders. Within Merck, Dr. Millogo informs the company’s vaccine implementation programs, WHO Prequalification of vaccines, as well as the clinical and manufacturing divisions on vaccine packaging and formulations as well as delivery technology suitable for low- and middle-income countries.
Prior to joining Merck, Dr. Millogo served for several years in John Snow, Inc, (JSI) a Non-Government Organization as Project Director of a 150 million-dollar US Government funded global initiative to reduce the risk of medical transmission of HIV/AIDS. In this position Dr. Millogo led the development, managed country, and international staff in 11 African and Caribbean countries, and oversaw the development of national policies, the supply and distribution of injection and healthcare waste management materials and the training of health workers.   
Prior to joining JSI, Dr Millogo worked at the World Health Organization (WHO) in Geneva/Switzerland supporting immunization programs in numerous African and Asian countries and conducting injection practice assessments. Before joining WHO, Jules had worked in the Ministry of Health of Burkina Faso in various positions from District Medical Officer to Director of the National Immunization Program, developing the national immunization policies and guidelines and implementing outbreak response to public health emergencies.
Dr. Millogo holds a Medical Degree from the University of Ouagadougou, and a Master of Science (MSc) in Epidemiology of Communicable Diseases from the London School of Hygiene & Tropical Medicine, United Kingdom. He also received numerous technical and management trainings through various organizations including the World Health Organization and the Japanese International Cooperation Agency.

Appearances:



Day 2 - Wednesday 3rd April @ 11:40

Panel: Partnerships between industry and vaccine implementation programs

  • What is needed to design tiered pricing for vaccines?
  • How is current vaccine supply being planned assured, particularly with LMICs?  
  • Navigating limited supply of vaccines market availability increases
  • How industry and government are working with NGOs and mechanisms like GAVI to make vaccines more accessible
  • MIC countries and affordability of vaccine supply programs.
last published: 26/Feb/24 13:16 GMT

back to speakers